摘要
目的 探究基于“肺与大肠相表里”理论采用通腑泻肺法治疗重症肺炎的效果和作用机制。方法 纳入本院2023年4月-2025年4月收治重症肺炎患者,共入组22例。依照随机数字表法划分2个小组,对照组(n=11)予以常规西医治疗,观察组(n=11)在此基础上予以通腑泻肺法治疗。根据临床治疗效果、中医证候积分、炎症因子评价2组治疗情况。结果 与对照组临床总有效率比较,观察组存在明显提高,组间有统计学差异(P<0.05)。中医证候积分(痰壅、气促、咳嗽、发热)评估显示,观察组治疗后各项得分相较对照组下降,组间有统计学差异(P<0.05)。炎症因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)]检测显示,观察组治疗后各指标水平相较对照组下降,组间有统计学差异(P<0.05)。结论 基于“肺与大肠相表里”理论采用通腑泻肺法治疗重症肺炎能提升临床疗效,有效缓解中医证候,其机制可能和减轻炎症反应有关。
关键词: 肺与大肠相表里;通腑泻肺法;重症肺炎
Abstract
Objective To explore the efficacy and mechanism of lung-clearing and purging therapy in treating severe pneumonia based on the theory of “lung and large intestine being internally and externally related.” Methods Twenty-two patients with severe pneumonia admitted to our hospital from April 2023 to April 2025 were included. They were randomly divided into two groups: a control group (n=11) receiving routine Western medicine treatment, and an observation group (n=11) receiving lung-clearing and purging therapy in addition to routine Western medicine treatment. The treatment outcomes of the two groups were evaluated based on clinical efficacy, TCM syndrome scores, and inflammatory factors. Results The total effective rate in the observation group was significantly higher than that in the control group (P<0.05). The TCM syndrome scores (phlegm accumulation, shortness of breath, cough, fever) showed a decrease in all categories after treatment in the observation group compared to the control group (P<0.05). The detection of inflammatory factors [interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP)] showed that the levels of each indicator in the observation group decreased compared with the control group after treatment, and the differences between the groups were statistically significant (P < 0.05). Conclusion Based on the theory of "lung and large intestine being internally and externally related," the method of purging the lungs and clearing the bowels can improve the clinical efficacy of treating severe pneumonia and effectively alleviate TCM syndromes. Its mechanism may be related to reducing the inflammatory response.
Key words: Lung and large intestine being internally and externally related; Purging the lungs and clearing the bowels; Severe pneumonia
参考文献 References
[1] 刘福松,谢连进,陆金海. 泻肺通腑汤加减联合哌拉西林他唑巴坦钠治疗重症肺炎痰热壅肺证的效果[J]. 基层医学论坛,2022,26(22):110-112.
[2] 胡秀恋. 通腑泻肺汤联合益生菌治疗重症肺炎合并胃肠功能障碍患儿的临床观察[J]. 基层医学论坛,2025, 29(27):9-11,18.
[3] 邵雪波,唐卫东,何燕燕,等. 宣肺通腑方对重症肺炎患者预后的影响[J]. 中国中西医结合急救杂志,2025,32(2): 155-159.
[4] 王鑫,梁群,王迪,等. 通腑泄热法结合腹部电针治疗重症肺炎合并胃肠功能障碍的疗效分析[J]. 中国中医急症,2025,34(1):134-137.
[5] 肖秋生,邓梦华,唐丽群,等. 泻热通腑方灌肠联合哌拉西林他唑巴坦钠治疗痰热内盛型重症肺炎的临床观察[J]. 中国处方药,2021,19(7):105-106.
[6] 李鹏飞,陈红,邢笑梅,等. 自拟通腑益肺汤联合喜炎平注射液对痰热壅肺型重症肺炎并Ⅱ型呼吸衰竭患者肺功能及血清炎性因子水平的影响[J]. 实用心脑肺血管病杂志,2018,26(7):89-93.
[7] 唐辉龙,李凯,陈远惠. 清肺通腑方治疗重症肺炎痰热壅肺证对患者FeNO水平及细胞免疫功能的影响[J]. 黑龙江中医药,2023,52(3):132-134.
[8] 朱文亮,黄晓佩,邱实,等. 自拟通腑益肺汤联合喜炎平注射液对痰热壅肺型重症肺炎并Ⅱ型呼吸衰竭效果、肺功能及炎性因子研究[J]. 罕少疾病杂志,2022,29(3):26-28.
[9] 李春雨,田园,李国勤. 清热通腑灌肠法联合无创通气治疗老年重症肺炎阳明腑实证临床研究[J]. 国际中医中药杂志,2021,43(6):546-551.
[10] 袁奕清,胡小军,陈瑶,等. 宣肺通腑汤联合双歧杆菌治疗老年重症肺炎合并胃肠功能障碍的临床观察[J]. 中国中医急症,2021,30(3):504-507.